Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Biodesix (BDSX) Interest Expenses (2019 - 2026)

Biodesix filings provide 8 years of Interest Expenses readings, the most recent being $2.0 million for Q1 2026.

  • On a quarterly basis, Interest Expenses rose 17.33% to $2.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $8.0 million, a 8.03% increase, with the full-year FY2025 number at $7.7 million, down 6.56% from a year prior.
  • Interest Expenses hit $2.0 million in Q1 2026 for Biodesix, down from $2.1 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $3.0 million in Q3 2022 to a low of $1.1 million in Q1 2022.
  • Median Interest Expenses over the past 5 years was $2.1 million (2025), compared with a mean of $2.1 million.
  • Biggest five-year swings in Interest Expenses: surged 110.29% in 2023 and later crashed 33.37% in 2025.
  • Biodesix's Interest Expenses stood at $2.6 million in 2022, then fell by 8.67% to $2.3 million in 2023, then dropped by 24.77% to $1.8 million in 2024, then increased by 17.52% to $2.1 million in 2025, then dropped by 3.98% to $2.0 million in 2026.
  • The last three reported values for Interest Expenses were $2.0 million (Q1 2026), $2.1 million (Q4 2025), and $2.1 million (Q3 2025) per Business Quant data.